APA način citiranja

Ogunmodede, J., Kolo, P., Katibi, I., & Omotoso, A. (2017). The Use of First Line Highly Active Anti-Retroviral Therapy (HAART) is Not Associated with Qtc Prolongation in HIV Patients. Ethiop J Health Sci.

Čikaški stil citiranja

Ogunmodede, James, Philip Kolo, Ibraheem Katibi, i Ayodele Omotoso. "The Use of First Line Highly Active Anti-Retroviral Therapy (HAART) Is Not Associated With Qtc Prolongation in HIV Patients." Ethiop J Health Sci 2017.

MLA način citiranja

Ogunmodede, James, Philip Kolo, Ibraheem Katibi, i Ayodele Omotoso. "The Use of First Line Highly Active Anti-Retroviral Therapy (HAART) Is Not Associated With Qtc Prolongation in HIV Patients." Ethiop J Health Sci 2017.